association between dystrophia myotonica type II and autoimmune disease

• Conditions: dystrophia myotonica type II; muscle disorder; 10003816; 10028396

• Registration Number: NL-OMON30830
• Lead Sponsor: Sint Maartenskliniek

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 64

Inclusion Criteria

dystrophia myotonica type II
informed consent

Exclusion Criteria

none

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>frequency of autoimmune disease according to clinical criteria or<br /><br>classification criteria in both cohorts</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>frequency of autoantibody fromation in both cohorts</p><br>